Paragon will sponsor an invitation-only reception held by Oregon Bioscience Association during the conference
PORTLAND, Ore. – Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, will sponsor a special reception during the JP Morgan 2016 Healthcare Conference, being held in San Francisco, January 11–14. The conference, which is now in its 34th year, is an invitation-only event intended to create an environment of collaboration by bringing together stakeholders in the corporate, investor and financial sectors to learn about and explore market and sector trends.
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic...
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals,...
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies,...
PORTLAND, Ore. — Paragon BioTeck, Inc., today announced that it has signed a distribution agreement with Horus Pharma for rights...
Recent U.S FDA Approval of Paragon’s NDA Clears the Way for Bausch + Lomb Commercialization TIGARD, Ore. & MADISON, N.J....
TIGARD, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies,...
TIGARD, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies,...
TIGARD, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies,...
